These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9512970)

  • 21. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease.
    Saitoh O; Kojima K; Sugi K; Matsuse R; Uchida K; Tabata K; Nakagawa K; Kayazawa M; Hirata I; Katsu K
    Am J Gastroenterol; 1999 Dec; 94(12):3513-20. PubMed ID: 10606313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome.
    Silberer H; Küppers B; Mickisch O; Baniewicz W; Drescher M; Traber L; Kempf A; Schmidt-Gayk H
    Clin Lab; 2005; 51(3-4):117-26. PubMed ID: 15819166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation.
    Kane SV; Sandborn WJ; Rufo PA; Zholudev A; Boone J; Lyerly D; Camilleri M; Hanauer SB
    Am J Gastroenterol; 2003 Jun; 98(6):1309-14. PubMed ID: 12818275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enteric protein loss as a marker of intestinal inflammatory activity in Crohn's disease: comparability of enteric clearance and stool concentration of alpha-1-antitrypsin?
    Hundegger K; Stufler M; Karbach U
    Z Gastroenterol; 1992 Oct; 30(10):722-8. PubMed ID: 1441675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fecal pyruvate kinase: a potential new marker for intestinal inflammation in children with inflammatory bowel disease.
    Czub E; Herzig KH; Szaflarska-Popawska A; Kiehne K; Socha P; Woś H; Kamińska B; Błaszczyński M; Cichy W; Bała G; Brodzicki J; Grzybowska-Chlebowczyk U; Walkowiak J
    Scand J Gastroenterol; 2007 Oct; 42(10):1147-50. PubMed ID: 17852864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease.
    Reinders CA; Jonkers D; Janson EA; Stockbrügger RW; Stobberingh EE; Hellström PM; Lundberg JO
    Scand J Gastroenterol; 2007 Oct; 42(10):1151-7. PubMed ID: 17852876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enzymes in feces: useful markers of chronic inflammatory bowel disease.
    Angriman I; Scarpa M; D'Incà R; Basso D; Ruffolo C; Polese L; Sturniolo GC; D'Amico DF; Plebani M
    Clin Chim Acta; 2007 May; 381(1):63-8. PubMed ID: 17368600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet activating factor in stool from patients with ulcerative colitis and Crohn's disease.
    Hocke M; Richter L; Bosseckert H; Eitner K
    Hepatogastroenterology; 1999; 46(28):2333-7. PubMed ID: 10521992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of fecal alpha-1-antitrypsin for detection of gastrointestinal bleeding in patients with gastric cancer.
    Saikawa Y; Kubota T; Ogawa S; Shimada A; Shibata S; Furukawa T; Yamamoto T; Kumai K; Yoshino K; Ishibiki K
    Anticancer Res; 1993; 13(3):619-22. PubMed ID: 8317889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fecal excretion and the clearance of alpha 1-antitrypsin in patients with Crohn's disease].
    López A; Hinojosa J; Miralles A; Primo J; Bermúdez JD
    Rev Esp Enferm Dig; 1993 Apr; 83(4):235-9. PubMed ID: 8494651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease.
    Marchesi JR; Holmes E; Khan F; Kochhar S; Scanlan P; Shanahan F; Wilson ID; Wang Y
    J Proteome Res; 2007 Feb; 6(2):546-51. PubMed ID: 17269711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease.
    Summers RW; Elliott DE; Qadir K; Urban JF; Thompson R; Weinstock JV
    Am J Gastroenterol; 2003 Sep; 98(9):2034-41. PubMed ID: 14499784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.
    Kolho KL; Raivio T; Lindahl H; Savilahti E
    Scand J Gastroenterol; 2006 Jun; 41(6):720-5. PubMed ID: 16716972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease.
    Foell D; Wittkowski H; Ren Z; Turton J; Pang G; Daebritz J; Ehrchen J; Heidemann J; Borody T; Roth J; Clancy R
    J Pathol; 2008 Oct; 216(2):183-92. PubMed ID: 18729068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Measurement of calprotectin in faeces].
    Jahnsen J; Røseth AG; Aadland E
    Tidsskr Nor Laegeforen; 2009 Apr; 129(8):743-5. PubMed ID: 19373299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laboratory evaluation of inflammatory bowel disease.
    Wong A; Bass D
    Curr Opin Pediatr; 2008 Oct; 20(5):566-70. PubMed ID: 18781120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Investigation of protein-losing enteropathy in pediatric patients].
    Sierra Salinas C; Vicioso Recio MI; Barco Galvez A; del Rio Mapelli L; Martinez Valverde A
    An Esp Pediatr; 1997 Aug; 47(2):144-50. PubMed ID: 9382345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.